Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Four-dimensional dose evaluation of inhomogeneous dose distributions planned for non-small cell lung cancer patients with lymph node involvement.
Nielsen TB, Hansen O, Schytte T, Brink C. Nielsen TB, et al. Acta Oncol. 2014 May;53(5):707-12. doi: 10.3109/0284186X.2013.835492. Epub 2013 Sep 12. Acta Oncol. 2014. PMID: 24028531 No abstract available.
Influence of dose calculation algorithms on the predicted dose distribution and NTCP values for NSCLC patients.
Nielsen TB, Wieslander E, Fogliata A, Nielsen M, Hansen O, Brink C. Nielsen TB, et al. Among authors: nielsen m. Med Phys. 2011 May;38(5):2412-8. doi: 10.1118/1.3575418. Med Phys. 2011. PMID: 21776775
A dual centre study of setup accuracy for thoracic patients based on cone-beam CT data.
Nielsen TB, Hansen VN, Westberg J, Hansen O, Brink C. Nielsen TB, et al. Radiother Oncol. 2012 Feb;102(2):281-6. doi: 10.1016/j.radonc.2011.11.012. Epub 2011 Dec 21. Radiother Oncol. 2012. PMID: 22196681
Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose.
Nielsen TB, Hansen O, Schytte T, Brink C. Nielsen TB, et al. Acta Oncol. 2014 Jan;53(1):119-25. doi: 10.3109/0284186X.2013.790560. Epub 2013 Apr 29. Acta Oncol. 2014. PMID: 23627917
Comparison of three immobilisation systems for radiation therapy in head and neck cancer.
Hansen CR, Christiansen RL, Nielsen TB, Bertelsen AS, Johansen J, Brink C. Hansen CR, et al. Among authors: nielsen tb. Acta Oncol. 2014 Mar;53(3):423-7. doi: 10.3109/0284186X.2013.813966. Epub 2013 Sep 24. Acta Oncol. 2014. PMID: 24063295 No abstract available.
Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer.
Schytte T, Nielsen TB, Brink C, Hansen O. Schytte T, et al. Among authors: nielsen tb. Acta Oncol. 2014 Mar;53(3):336-41. doi: 10.3109/0284186X.2013.868035. Epub 2013 Dec 26. Acta Oncol. 2014. PMID: 24369735 Clinical Trial.
Impact of 4D image quality on the accuracy of target definition.
Nielsen TB, Hansen CR, Westberg J, Hansen O, Brink C. Nielsen TB, et al. Australas Phys Eng Sci Med. 2016 Mar;39(1):103-12. doi: 10.1007/s13246-015-0400-3. Epub 2015 Nov 17. Australas Phys Eng Sci Med. 2016. PMID: 26577711
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.
Møller DS, Nielsen TB, Brink C, Hoffmann L, Lutz CM, Drøgemüller Lund M, Hansen O, Schytte T, Khalil AA, Knap MM, Nyhus CH, Ottosson W, Sibolt P, Borissova S, Josipovic M, Persson G, Appelt AL. Møller DS, et al. Among authors: nielsen tb. Radiother Oncol. 2017 Aug;124(2):311-317. doi: 10.1016/j.radonc.2017.06.022. Epub 2017 Jul 5. Radiother Oncol. 2017. PMID: 28688525 Clinical Trial.
Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib.
Aarup K, Rotbain EC, Enggaard L, Pedersen RS, Bergmann OJ, Thomsen RH, Frederiksen M, Frederiksen H, Nielsen T, Christiansen I, Andersen MA, Niemann CU. Aarup K, et al. Eur J Haematol. 2020 Nov;105(5):646-654. doi: 10.1111/ejh.13499. Epub 2020 Aug 26. Eur J Haematol. 2020. PMID: 32736410
Antibodies, Immunity, and COVID-19.
Spellberg B, Nielsen TB, Casadevall A. Spellberg B, et al. Among authors: nielsen tb. JAMA Intern Med. 2020 Nov 24. doi: 10.1001/jamainternmed.2020.7986. Online ahead of print. JAMA Intern Med. 2020. PMID: 33231673 No abstract available.
80 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page